Cargando…
Co-administration of Chrysin and Luteolin with Cisplatin and Topotecan Exhibits a Variable Therapeutic Value in Human Cancer Cells, HeLa
[Image: see text] Combinational treatment is a promising strategy for better cancer treatment outcomes. Chrysin and luteolin have demonstrated effective anticancer activity. Cisplatin and topotecan are commonly used for the treatment of human cancers. However, various side effects including drug res...
Autores principales: | Raina, Ritu, Hussain, Arif, Almutary, Abdulmajeed G., Haque, Shafiul, Raza, Tasleem, D’Souza, Ashley Cletus, Subramani, Sachin, Sajeevan, Akash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633856/ https://www.ncbi.nlm.nih.gov/pubmed/37970041 http://dx.doi.org/10.1021/acsomega.3c04443 |
Ejemplares similares
-
Chrysin Modulates Aberrant Epigenetic Variations and Hampers Migratory Behavior of Human Cervical (HeLa) Cells
por: Raina, Ritu, et al.
Publicado: (2022) -
Luteolin inhibits proliferation, triggers apoptosis and modulates Akt/mTOR and MAP kinase pathways in HeLa cells
por: Raina, Ritu, et al.
Publicado: (2021) -
Luteolin Causes 5′CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells
por: Pramodh, Sreepoorna, et al.
Publicado: (2022) -
Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells
por: Sundaram, Madhumitha Kedhari, et al.
Publicado: (2019) -
Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa
por: Afroze, Nazia, et al.
Publicado: (2022)